000 01797 a2200541 4500
005 20250518085707.0
264 0 _c20201118
008 202011s 0 0 eng d
022 _a1476-5551
024 7 _a10.1038/s41375-020-0770-8
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aLocatelli, Franco
245 0 0 _aBlinatumomab versus historical standard therapy in pediatric patients with relapsed/refractory Ph-negative B-cell precursor acute lymphoblastic leukemia.
_h[electronic resource]
260 _bLeukemia
_c09 2020
300 _a2473-2478 p.
_bdigital
500 _aPublication Type: Letter; Research Support, Non-U.S. Gov't
650 0 4 _aAdolescent
650 0 4 _aAntibodies, Bispecific
_xtherapeutic use
650 0 4 _aAntineoplastic Agents
_xtherapeutic use
650 0 4 _aChild
650 0 4 _aChild, Preschool
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aMale
650 0 4 _aPhiladelphia Chromosome
650 0 4 _aPrecursor B-Cell Lymphoblastic Leukemia-Lymphoma
_xdrug therapy
650 0 4 _aRecurrence
700 1 _aWhitlock, James A
700 1 _aPeters, Christina
700 1 _aChen-Santel, Christiane
700 1 _aChia, Victoria
700 1 _aDennis, Robyn M
700 1 _aHeym, Kenneth M
700 1 _aKatz, Aaron J
700 1 _aKelsh, Michael A
700 1 _aSposto, Richard
700 1 _aTu, Huakang
700 1 _aTuglus, Catherine A
700 1 _aVerma, Anupam
700 1 _aVinti, Luciana
700 1 _aWilkes, Jennifer J
700 1 _aZubarovskaja, Nathalya
700 1 _aZugmaier, Gerhard
700 1 _avon Stackelberg, Arend
700 1 _aSun, Weili
773 0 _tLeukemia
_gvol. 34
_gno. 9
_gp. 2473-2478
856 4 0 _uhttps://doi.org/10.1038/s41375-020-0770-8
_zAvailable from publisher's website
999 _c30669310
_d30669310